Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06413134 · ClinicalTrials.gov registry record · NA
KPAP Adherence Crossover Study
A NA study, sponsored by SleepRes.
- Not yet
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT06413134 is a NA study that has not yet begun recruiting, run by SleepRes. The registered enrollment target is 30 participants.
The verdict
NCT06413134, a NA study, has not yet begun recruiting, sponsored by SleepRes.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
A device able to provide less positive airway pressure (PAP) for the entire duration of inspiration and roughly half the duration of expiration, designated KPAP, is being developed by SleepRes for the treatment of obstructive sleep apnea (OSA). In prior studies, the administration of higher inspiratory than expiratory PAP did not substantially increase treatment efficacy or adherence to continuous PAP (CPAP), which remains low. In our recent investigation, we demonstrated that the addition of a resistor to the CPAP circuit to reduce inspiratory PAP increased subjective comfort. In another study, we showed that KPAP improved subjective comfort during wakefulness vs. fixed CPAP, while maintaining treatment efficacy. The present study, KPAP Adherence 1, is a randomized, crossover study designed to examine whether KPAP can improve adherence over APAP as an at home treatment for OSA.
Interventions
- DEVICE KPAP
- DEVICE APAP
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2026-07-01 |
| Est. Completion | 2026-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06413134
The ClinicalTrials.gov registry entry for NCT06413134 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is SleepRes, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which KPAP is the first listed.
NCT06413134 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06413134 about?
NCT06413134 is a clinical study titled "KPAP Adherence Crossover Study". A device able to provide less positive airway pressure (PAP) for the entire duration of inspiration and roughly half the duration of expiration, designated KPAP, is being developed by SleepRes for the treatment of obstructive sleep apnea (OSA). In prior studies, the administration of higher inspirat...
What is the current status of trial NCT06413134?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2026-07-01. Estimated completion is 2026-12-31.
What interventions are being tested in trial NCT06413134?
The interventions under investigation include: KPAP (DEVICE), APAP (DEVICE).
Who is sponsoring clinical trial NCT06413134?
This trial is sponsored by SleepRes, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.